Cbdmd launches powerful new product designed to reduce pain - cbdmd max

Formulated with proprietary cannabinoid blend and clinically proven ingredient to address paincharlotte, north carolina--(newsfile corp. - october 18, 2022) - cbdmd, inc. (nyse american: ycbd) (nyse american: ycbdpa), one of the nation's leading, highly trusted and widely recognized cbd companies, announced their latest product launch geared toward the over 50 million americans who suffer from some form of everyday pain or discomfort. cbdmd max features their innovative formula that combines cbdmd's proprietary cannabinoid blend with univestin.
YCBD Ratings Summary
YCBD Quant Ranking